Evidence map›Paper›PMID 40294030›Full record

ArticlePLoS pathogens2025

In depth sequencing of a serially sampled household cohort reveals the within-host dynamics of Omicron SARS-CoV-2 and rare selection of novel spike variants.

Emily E Bendall, Derek Dimcheff, Leigh Papalambros, William J Fitzsimmons, Yuwei Zhu, Jonathan Schmitz, Natasha Halasa, James Chappell, Emily T Martin, Jessica E Biddle and 6 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Emily E BendallDepartment of Microbiology & Immunology, University of Michigan, Ann Arbor, Michigan, United States of America.
Derek DimcheffDepartment of Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States of America.
Leigh PapalambrosDepartment of Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States of America.
William J FitzsimmonsDepartment of Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States of America.
Yuwei ZhuDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
Jonathan SchmitzDepartment of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
Natasha HalasaDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
James ChappellDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
Emily T MartinDepartment of Epidemiology, University of Michigan, Ann Arbor, Michigan, United States of America.
Jessica E BiddleCenters for Disease Control and Prevention, Atlanta, GeorgiaUnited States of America.
Sarah E Smith-JeffcoatCenters for Disease Control and Prevention, Atlanta, GeorgiaUnited States of America.
Melissa A RolfesCenters for Disease Control and Prevention, Atlanta, GeorgiaUnited States of America.
Alexandra MellisCenters for Disease Control and Prevention, Atlanta, GeorgiaUnited States of America.
H Keipp TalbotDepartment of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee Tennessee, United States of America.
Carlos GrijalvaDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
Adam S LauringDepartment of Microbiology & Immunology, University of Michigan, Ann Arbor, Michigan, United States of America.ORCID 0000-0003-2906-8335

Funding

NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities75N93021C00015 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI HENSLEY, SCOTT · 2021 to 2025
$50.7M
The Michigan Infectious Disease Genomics (MIDGE) CenterU19AI181767 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LAURING, ADAM, SNITKIN, EVAN · 2024 to 2024
$6.2M
Evolution and Transmission of Influenza Virus in Natural Human InfectionR01AI148371 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LAURING, ADAM, MARTIN, EMILY TOTH · 2020 to 2024
$3.6M
Mentoring in transmission of influenza and strategies for preventionK24AI148459 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI GRIJALVA, CARLOS G · 2020 to 2024
$893k
NIAID NIH HHS 75N93021C00015NIAID NIH HHS K24 AI148459NIAID NIH HHS R01 AI148371NIAID NIH HHS U19 AI181767
6 · The paper itself

Abstract

SARS-CoV-2 has undergone repeated and rapid evolution to circumvent host immunity. However, outside of prolonged infections in immunocompromised hosts, within-host positive selection has rarely been detected. Here we combine daily longitudinal sampling of individuals with replicate sequencing to increase the accuracy of and lower the threshold for variant calling. We sequenced 577 specimens from 105 individuals in a household cohort during the BA.1/BA.2 variant period. Individuals exhibited extremely low viral diversity, and we estimated a low within-host evolutionary rate. Within-host dynamics were dominated by genetic drift and purifying selection. Positive selection was rare but highly concentrated in spike. A Wright Fisher Approximate Bayesian Computational model identified positive selection at 14 loci with 7 in spike, including S:448 and S:339. This detectable immune-mediated selection is unusual in acute respiratory infections and may be caused by the relatively narrow antibody repertoire in individuals during the early Omicron phase of the SARS-CoV-2 pandemic.

Indexed as

COVID-19SARS-CoV-2Spike Glycoprotein, CoronavirusAdultBayes TheoremCohort StudiesEvolution, MolecularFemaleGenetic VariationHigh-Throughput Nucleotide SequencingHumansMaleMiddle AgedSelection, GeneticSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Identifiers

PMID40294030
PMCPMC12074595

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.